Location Los Angeles, California, United States Regions Greater Los Angeles Area, West Coast, Western US Gender Male
LinkedIn View on LinkedIn
Mitch Clark is the Chief Regulatory and Quality Officer at Atara Biotherapeutics with responsibility global regulatory strategy and quality assurance. Mitch has over 30 years of global Regulatory Affairs, Quality Assurance, and Drug Development experience in the pharmaceutical industry. His professional experience includes senior management roles
at a number of organizations such as Schering AG (based in its UK and Berlin offices), American Pharmaceutical Partners (APP), Abraxis Bioscience, Celgene Corporation, and Nantworks Group of Companies.
Among his significant previous positions, Mitch served as the Senior Vice President Regulatory Affairs at Los Angeles-based Nantworks Group of Companies where he established the Regulatory Affairs and Quality Assurance functions.
He was Senior Vice President, Regulatory Affairs and Clinical Quality Assurance at Abraxis where he created and managed the regulatory team responsible for filing the initial IND and obtaining the global regulatory approvals of Abraxane®, the first albumin-bound nanoparticle product for the treatment of solid tumors.
Earlier in his career, he worked for large and small organizations. Most notably, he gained valuable international experience in positions of increasing responsibility with Schering AG, working in the Berlin head office and UK subsidiary where he played a key role in the global approvals of the first-in-class gadolinium-based MRI contrast agent, Magnevist®.
Mitch holds an Honors Degree in Pharmacy from The University of Nottingham, England. He enjoys a wide range of outdoor pursuits including canoeing, sailing and motorcycling.
